{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:20:52Z","timestamp":1782919252237,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12185-020-02970-2","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T18:03:33Z","timestamp":1597255413000},"page":"864-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphoplasmacytic lymphoma in a patient with Birt\u2013Hogg\u2013Dub\u00e9 syndrome"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1060-9218","authenticated-orcid":false,"given":"Keiji","family":"Kurata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoe","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saegusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"issue":"12","key":"2970_CR1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","volume":"113","author":"AR Birt","year":"1977","unstructured":"Birt AR, Hogg GR, Dube WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977;113(12):1674\u20137.","journal-title":"Arch Dermatol"},{"issue":"22","key":"2970_CR2","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1038\/onc.2010.628","volume":"30","author":"TP Cash","year":"2011","unstructured":"Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGFbeta-mediated transcription. Oncogene. 2011;30(22):2534\u201346.","journal-title":"Oncogene"},{"issue":"3","key":"2970_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cas.12601","volume":"106","author":"M Furuya","year":"2015","unstructured":"Furuya M, Hong SB, Tanaka R, Kuroda N, Nagashima Y, Nagahama K, et al. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dube syndrome. Cancer Sci. 2015;106(3):315\u201323.","journal-title":"Cancer Sci"},{"issue":"12","key":"2970_CR4","doi-asserted-by":"crossref","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","volume":"5","author":"SB Hong","year":"2010","unstructured":"Hong SB, Oh H, Valera VA, Baba M, Schmidt LS, Linehan WM. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE. 2010;5(12):e15793.","journal-title":"PLoS ONE"},{"issue":"3","key":"2970_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.2009.072009","volume":"47","author":"V Hudon","year":"2010","unstructured":"Hudon V, Sabourin S, Dydensborg AB, Kottis V, Ghazi A, Paquet M, et al. Renal tumour suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin. J Med Genet. 2010;47(3):182\u20139.","journal-title":"J Med Genet"},{"issue":"4","key":"2970_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.2009.070565","volume":"47","author":"M Kunogi","year":"2010","unstructured":"Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, et al. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and\/or multiple lung cysts are the presenting feature. J Med Genet. 2010;47(4):281\u20137.","journal-title":"J Med Genet"},{"issue":"1","key":"2970_CR7","doi-asserted-by":"crossref","first-page":"E1043","DOI":"10.1002\/humu.21130","volume":"31","author":"DH Lim","year":"2010","unstructured":"Lim DH, Rehal PK, Nahorski MS, Macdonald F, Claessens T, Van Geel M, et al. A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene. Hum Mutat. 2010;31(1):E1043\u201351.","journal-title":"Hum Mutat"},{"issue":"2","key":"2970_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002;2(2):157\u201364.","journal-title":"Cancer Cell"},{"key":"2970_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","volume":"640","author":"LS Schmidt","year":"2018","unstructured":"Schmidt LS, Linehan WM. FLCN: the causative gene for Birt-Hogg-Dube syndrome. Gene. 2018;640:28\u201342.","journal-title":"Gene"},{"issue":"9","key":"2970_CR10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jmg.2007.049874","volume":"44","author":"Y Gunji","year":"2007","unstructured":"Gunji Y, Akiyoshi T, Sato T, Kurihara M, Tominaga S, Takahashi K, et al. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet. 2007;44(9):588\u201393.","journal-title":"J Med Genet"},{"issue":"13","key":"2970_CR11","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","volume":"121","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121(13):2522\u20138.","journal-title":"Blood"},{"issue":"15","key":"2970_CR12","first-page":"4583","volume":"63","author":"SK Khoo","year":"2003","unstructured":"Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, et al. Inactivation of BHD in sporadic renal tumors. Cancer Res. 2003;63(15):4583\u20137.","journal-title":"Cancer Res"},{"issue":"10","key":"2970_CR13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrurol.2015.206","volume":"12","author":"LS Schmidt","year":"2015","unstructured":"Schmidt LS, Linehan WM. Molecular genetics and clinical features of Birt-Hogg-Dube syndrome. Nat Rev Urol. 2015;12(10):558\u201369.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"2970_CR14","first-page":"751","volume":"30","author":"R Palmirotta","year":"2010","unstructured":"Palmirotta R, Savonarola A, Ludovici G, Donati P, Cavaliere F, De Marchis ML, et al. Association between Birt Hogg Dube syndrome and cancer predisposition. Anticancer research. 2010;30(3):751\u20137.","journal-title":"Anticancer research."},{"issue":"3","key":"2970_CR15","first-page":"278","volume":"16","author":"OK Steinlein","year":"2018","unstructured":"Steinlein OK, Ertl-Wagner B, Ruzicka T, Sattler EC. Birt-Hogg-Dube syndrome: an underdiagnosed genetic tumor syndrome. Journal der Deutschen Dermatologischen Gesellschaft. 2018;16(3):278\u201383.","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft."},{"issue":"22","key":"2970_CR16","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","volume":"121","author":"S Poulain","year":"2013","unstructured":"Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121(22):4504\u201311.","journal-title":"Blood"},{"issue":"9","key":"2970_CR17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333.","journal-title":"N Engl J Med"},{"issue":"25","key":"2970_CR18","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2016-01-695098","volume":"127","author":"G Yang","year":"2016","unstructured":"Yang G, Buhrlage SJ, Tan L, Liu X, Chen J, Xu L, et al. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. 2016;127(25):3237\u201352.","journal-title":"Blood"},{"issue":"3","key":"2970_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20131424","volume":"211","author":"JQ Wang","year":"2014","unstructured":"Wang JQ, Jeelall YS, Beutler B, Horikawa K, Goodnow CC. Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance. J Exp Med. 2014;211(3):413\u201326.","journal-title":"J Exp Med"},{"issue":"9","key":"2970_CR20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2016.71.0814","volume":"35","author":"ZR Hunter","year":"2017","unstructured":"Hunter ZR, Yang G, Xu L, Liu X, Castillo JJ, Treon SP. Genomics, signaling, and treatment of waldenstrom macroglobulinemia. J Clin Oncol. 2017;35(9):994\u20131001.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2970_CR21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","volume":"78","author":"X Yu","year":"2018","unstructured":"Yu X, Li W, Deng Q, Li L, Hsi ED, Young KH, et al. MYD88 L265P mutation in lymphoid malignancies. Cancer Res. 2018;78(10):2457\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"2970_CR22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","volume":"100","author":"M Baba","year":"2008","unstructured":"Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, et al. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst. 2008;100(2):140\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2970_CR23","doi-asserted-by":"crossref","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","volume":"3","author":"J Chen","year":"2008","unstructured":"Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, et al. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One. 2008;3(10):e3581.","journal-title":"PLoS One"},{"issue":"44","key":"2970_CR24","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","volume":"106","author":"Y Hasumi","year":"2009","unstructured":"Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA. 2009;106(44):18722\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"8","key":"2970_CR25","doi-asserted-by":"crossref","first-page":"e12107","DOI":"10.14814\/phy2.12107","volume":"2","author":"D Khabibullin","year":"2014","unstructured":"Khabibullin D, Medvetz DA, Pinilla M, Hariharan V, Li C, Hergrueter A, et al. Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cells. Physiol Rep. 2014;2(8):e12107.","journal-title":"Physiol Rep."},{"issue":"5","key":"2970_CR26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2015.177","volume":"88","author":"J Chen","year":"2015","unstructured":"Chen J, Huang D, Rubera I, Futami K, Wang P, Zickert P, et al. Disruption of tubular Flcn expression as a mouse model for renal tumor induction. Kidney Int. 2015;88(5):1057\u201369.","journal-title":"Kidney Int"},{"issue":"21","key":"2970_CR27","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/1078-0432.CCR-16-0609","volume":"22","author":"ZX Ying","year":"2016","unstructured":"Ying ZX, Jin M, Peterson LF, Bernard D, Saiya-Cork K, Yildiz M, et al. Recurrent mutations in the MTOR regulator RRAGC in follicular lymphoma. Clin Cancer Res. 2016;22(21):5383\u201393.","journal-title":"Clin Cancer Res"},{"issue":"42","key":"2970_CR28","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","volume":"103","author":"M Baba","year":"2006","unstructured":"Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA. 2006;103(42):15552\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2970_CR29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood-2012-02-410407","volume":"120","author":"M Baba","year":"2012","unstructured":"Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, et al. The folliculin-FNIP1 pathway deleted in human Birt\u2013Hogg\u2013Dub\u00e9 syndrome is required for murine B-cell development. Blood. 2012;120(6):1254\u201361.","journal-title":"Blood"},{"issue":"5","key":"2970_CR30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2012.02.019","volume":"36","author":"H Park","year":"2012","unstructured":"Park H, Staehling K, Tsang M, Appleby MW, Brunkow ME, Margineantu D, et al. Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity. 2012;36(5):769\u201381.","journal-title":"Immunity"},{"issue":"11","key":"2970_CR31","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.4049\/jimmunol.1900395","volume":"203","author":"JA Ram\u00edrez","year":"2019","unstructured":"Ram\u00edrez JA, Iwata T, Park H, Tsang M, Kang J, Cui K, et al. Folliculin interacting protein 1 maintains metabolic homeostasis during B Cell development by modulating AMPK, mTORC1, and TFE3. J Immunol. 2019;203(11):2899\u2013908.","journal-title":"J Immunol."},{"issue":"12","key":"2970_CR32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","volume":"97","author":"CD Vocke","year":"2005","unstructured":"Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, et al. High frequency of somatic frameshift BHD gene mutations in Birt\u2013Hogg\u2013Dub\u00e9-associated renal tumors. J Natl Cancer Inst. 2005;97(12):931\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2970_CR33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.jid.5700592","volume":"127","author":"MA van Steensel","year":"2007","unstructured":"van Steensel MA, Verstraeten VL, Frank J, Kelleners-Smeets NW, Poblete-Guti\u00e9rrez P, Marcus-Soekarman D, et al. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt\u2013Hogg\u2013Dub\u00e9 patients. J Invest Dermatol. 2007;127(3):588\u201393.","journal-title":"J Invest Dermatol."},{"issue":"5","key":"2970_CR34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1183\/09031936.00132707","volume":"32","author":"BA Fr\u00f6hlich","year":"2008","unstructured":"Fr\u00f6hlich BA, Zeitz C, M\u00e1ty\u00e1s G, Alkadhi H, Tuor C, Berger W, et al. Novel mutations in the folliculin gene associated with spontaneous pneumothorax. Eur Respir J. 2008;32(5):1316\u201320.","journal-title":"Eur Respir J"},{"issue":"8","key":"2970_CR35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/humu.21519","volume":"32","author":"MS Nahorski","year":"2011","unstructured":"Nahorski MS, Reiman A, Lim DH, Nookala RK, Seabra L, Lu X, et al. Birt Hogg-Dub\u00e9 syndrome-associated FLCN mutations disrupt protein stability. Hum Mutat. 2011;32(8):921\u20139.","journal-title":"Hum Mutat"},{"issue":"6","key":"2970_CR36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/gcc.20872","volume":"50","author":"JN Benhammou","year":"2011","unstructured":"Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, et al. Identification of intragenic deletions and duplication in the FLCN gene in Birt\u2013Hogg\u2013Dub\u00e9 syndrome. Genes Chromosomes Cancer. 2011;50(6):466\u201377.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2970_CR37","doi-asserted-by":"crossref","first-page":"103820","DOI":"10.1016\/j.ejmg.2019.103820","volume":"63","author":"Y Enomoto","year":"2020","unstructured":"Enomoto Y, Namba Y, Hoshika Y, Komemushi Y, Mitani K, Kume H, et al. A case of Birt\u2013Hogg\u2013Dub\u00e9 syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic. Eur J Med Genet. 2020;63(4):103820.","journal-title":"Eur J Med Genet."},{"issue":"3","key":"2970_CR38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10689-012-9593-8","volume":"12","author":"FH Menko","year":"2013","unstructured":"Menko FH, Johannesma PC, van Moorselaar RJ, Reinhard R, van Waesberghe JH, Thunnissen E, et al. A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation. Fam Cancer. 2013;12(3):373\u20139.","journal-title":"Fam Cancer"},{"issue":"7","key":"2970_CR39","doi-asserted-by":"crossref","first-page":"e66775","DOI":"10.1371\/journal.pone.0066775","volume":"8","author":"LA Laviolette","year":"2013","unstructured":"Laviolette LA, Wilson J, Koller J, Neil C, Hulick P, Rejtar T, et al. Human folliculin delays cell cycle progression through late S and G2\/M-phases: effect of phosphorylation and tumor associated mutations. PLoS One. 2013;8(7):e66775.","journal-title":"PLoS One"},{"issue":"21","key":"2970_CR40","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1093\/hmg\/ddt288","volume":"22","author":"MN Luijten","year":"2013","unstructured":"Luijten MN, Basten SG, Claessens T, Vernooij M, Scott CL, Janssen R, et al. Birt-Hogg-Dube syndrome is a novel ciliopathy. Hum Mol Genet. 2013;22(21):4383\u201397.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2970_CR41","first-page":"354","volume":"26","author":"H Hasumi","year":"2017","unstructured":"Hasumi H, Hasumi Y, Baba M, Nishi H, Furuya M, Vocke CD, et al. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation. Hum Mol Genet. 2017;26(2):354\u201366.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2970_CR42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, et al. Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 2009;10(12):1199\u2013206.","journal-title":"Lancet Oncol"},{"key":"2970_CR43","unstructured":"LOVD. The Leiden Open variation Database, https:\/\/databases.lovd.nl\/shared\/genes\/FLCN. Accessed 6 July 2020."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02970-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:11:50Z","timestamp":1628727110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02970-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2970"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02970-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All of the authors, except one, report that they have no conflict of interest to disclose. Dr. Minami reports the following grants outside the submitted work during the period of the study: personal fees, and other from Chugai; grants and personal fees from Eizai.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional board on ethics, at Kobe University Hospital and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The patient provided written consent for all the investigations carried out in this study and for the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}